According to the most recent National Health and Nutrition Examination survey, roughly two-thirds of the adults in the United States are overweight, slowly closing the gap between themselves and the one-third of Americans considered obese. Analyzing the protein from lipid-rich tissues helps researchers understand the disease that kills about 300,000 people each year in the U.S. Additionally, obesity is linked to heart disease, stroke, cancer and diabetes.
PressureBiosciences, Inc. (NASDAQ: PBIO) developed Pressure Cycling Technology (PCT) which uses cycles of hydrostatic pressure, as well as other patented technology applicable in the life sciences field for genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics and protein purification.
The company recently rolled out the new detergent-free ProteoSolveLRS Kit, to be used in collaboration with PCT to extract proteins from lipid-rich samples. The ProteoSolveLRS lack of detergents gives it an upper hand over traditional methods that can produce disappointing results, thereby interfering with analytical methods.
According to Pressure Biosciences, when ProteoSolveLRS is used with PCT, it is possible to divide the lipid and protein components within a sample, allowing for higher protein recovery and reproducibility compared to traditional detergent-based methods. It also allows researchers to identify novel proteins, analyze lipid composition and discover biomarkers, all important to the fight against obesity.
Please see disclaimer on QualityStocks.net website
$4.26 (02/15/08)
